pumitamig (BNT327) - BioNTech, BMS
Early ctDNA and QVT dynamics are associated with early clinical activity in patients with ES-SCLC treated with first-line pumitamig plus chemotherapy: an exploratory phase 2 analysis (SITC 2026) - Oct 2, 2026 - Abstract #25; Pres time: Nov 6, 2026; 10:00 AM - 07:00 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available 
Circulating tumor DNA • Clinical • P2 data • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
https://www.sitcancer.org/2026/abstracts/titles-and-publications?SITC%202026%20Abstracts%5BhitsPerPage%5D=100
 
Secil Koseoglu; Chiara Dalle Fratte; Kezi Ünsal-Kaçmaz; John Heymach; Byoung Chul Cho; Ahmet Sezer; Cengiz Karaçin; Isaac Dai; Tolga Tuncel; Carolin Pütter; Kathrin Makulla; Sebastian Brachtendorf; Roman Matern; Aurora OBrate; Claudia-Nanette Gann; Ilhan Celik; Özlem Türeci; Ugur Sahin
 
Oct 2, 2026
 
Prev Next